CIK: 0001493215 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 14, 2018
Total Value ($000): $1,050,780 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | 14,969,744 | $258,228 | 24.6% | $16.31 | 0.0% | COM | 77313F106 |
| PTCT | PTC Therapeutics Inc | 4,137,960 | $111,973 | 10.7% | $13.46 | +88.2% | COM | 69366J200 |
| BMY | BRISTOL MYERS SQUIBB CO | 1,096,386 | $69,346 | 6.6% | $43.52 | +10.5% | COM | 110122108 |
| RGNX | Regenxbio Inc | 1,877,767 | $56,051 | 5.3% | $22.14 | +31.5% | COM | 75901B107 |
| SRPT | Sarepta Therapeutics Inc | 688,271 | $50,994 | 4.9% | $66.68 | 0.0% | COM | 803607100 |
| — | ACHILLION PHARMACEUTICALS IN | 13,496,902 | $50,074 | 4.8% | $3.82 | — | COM | 00448Q201 |
| — | Dicerna Pharmaceuticals Inc | 5,029,462 | $48,082 | 4.6% | $10.56 | — | COM | 253031108 |
| — | Agenus Inc | 9,313,556 | $43,867 | 4.2% | $6.00 | — | COM NEW | 00847G705 |
| — | La Jolla Pharmaceutical Co | 1,122,540 | $33,429 | 3.2% | $25.70 | — | COM PAR $.0001 2 | 503459604 |
| ALNY | Alnylam Pharmaceuticals Inc | 246,229 | $29,326 | 2.8% | $75.05 | +71.8% | COM | 02043Q107 |
| — | Avexis Inc | 236,425 | $29,217 | 2.8% | $33.55 | — | COM | 05366U100 |
| ABUS | Arbutus Biopharma Corp | 5,151,615 | $25,758 | 2.5% | $3.27 | +62.1% | COM | 03879J100 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 456,921 | $22,069 | 2.1% | $39.19 | — | COM | 37890U108 |
| — | CORIUM INTL INC | 1,910,522 | $21,914 | 2.1% | $8.35 | — | COM | 21887L107 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 2,916,561 | $21,028 | 2.0% | $6.16 | 0.0% | COM | 04280A100 |
| VCEL | Vericel Corp | 2,067,916 | $20,576 | 2.0% | $5.96 | +38.7% | COM | 92346J108 |
| MASI | Masimo Corp | 232,000 | $20,404 | 1.9% | $76.41 | +14.1% | COM | 574795100 |
| EW | Edwards Lifesciences Corp | 145,246 | $20,265 | 1.9% | $37.73 | +15.1% | COM | 28176E108 |
| — | Armo Biosciences Inc | 413,892 | $13,969 | 1.3% | $33.75 | — | COM | 04225U104 |
| — | Myokardia Inc | 259,670 | $12,672 | 1.2% | $42.84 | — | COM | 62857M105 |
| LIVN | LivaNova PLC | 140,000 | $12,390 | 1.2% | $85.17 | 0.0% | SHS | G5509L101 |
| QURE | Uniqure NV | 406,667 | $9,557 | 0.9% | $15.23 | +43.2% | SHS | N90064101 |
| — | VIVEVE MED INC | 2,557,559 | $9,361 | 0.9% | $4.53 | — | COM NEW | 92852W204 |
| VRAYQ | Viewray Inc | 1,358,711 | $8,737 | 0.8% | $6.34 | +31.5% | COM | 92672L107 |
| — | Nuvectra Corp | 507,061 | $6,602 | 0.6% | $13.02 | — | COM | 67075N108 |
| — | Bovie Medical Corp | 1,931,948 | $5,738 | 0.5% | $3.09 | — | COM | 10211F100 |
| — | Novavax Inc | 2,726,504 | $5,726 | 0.5% | $2.10 | — | COM | 670002104 |
| — | Odonate Therapeutics Inc | 274,544 | $5,303 | 0.5% | $22.75 | — | COM | 676079106 |
| — | PROTEOSTASIS THERAPEUTICS IN | 1,104,940 | $5,248 | 0.5% | $5.83 | — | COM | 74373B109 |
| — | Solid Biosciences Inc | 675,771 | $4,612 | 0.4% | $6.82 | — | COM | 83422E105 |
| CDNA | CareDx Inc | 560,600 | $4,468 | 0.4% | $6.16 | 0.0% | COM | 14167L103 |
| — | Homology Medicines Inc | 225,000 | $4,208 | 0.4% | $18.70 | — | COM | 438083107 |
| — | VIVUS INC | 4,000,000 | $2,500 | 0.2% | $0.63 | — | NOTE 4.500% 5/0 | 928551AB6 |
| ARGX | ARGENX SE | 25,457 | $2,048 | 0.2% | $21.81 | — | SPONSORED ADR | 04016X101 |
| OSUR | OraSure Technologies Inc | 117,291 | $1,981 | 0.2% | $13.47 | +40.8% | COM | 68554V108 |
| — | Novus Therapeutics Inc | 300,000 | $1,512 | 0.1% | $5.04 | — | COM | 67011N105 |
| — | Adverum Biotechnologies Inc | 175,208 | $1,016 | 0.1% | $5.80 | — | COM | 00773U108 |
| — | MOTUS GI HLDGS INC | 118,478 | $531 | 0.1% | $4.48 | — | COM | 62014P108 |